H.B. Fuller (NYSE:FUL) Receives $75.60 Consensus PT from Brokerages

H.B. Fuller (NYSE:FUL) has been assigned a consensus rating of “Hold” from the six ratings firms that are covering the company, MarketBeat reports. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is $75.60.

A number of analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft decreased their price objective on H.B. Fuller from $75.00 to $72.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd. Citigroup cut their price target on shares of H.B. Fuller from $78.00 to $68.00 and set a “neutral” rating on the stock in a research report on Friday, January 3rd. Vertical Research cut shares of H.B. Fuller from a “buy” rating to a “hold” rating in a research report on Monday, January 6th. JPMorgan Chase & Co. cut their price target on shares of H.B. Fuller from $70.00 to $60.00 and set an “underweight” rating on the stock in a research report on Friday, January 17th. Finally, Seaport Res Ptn cut shares of H.B. Fuller from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 5th.

H.B. Fuller Stock Performance

NYSE FUL opened at $53.86 on Friday. The company has a market capitalization of $2.92 billion, a price-to-earnings ratio of 23.31, a PEG ratio of 1.13 and a beta of 1.41. H.B. Fuller has a twelve month low of $53.80 and a twelve month high of $87.67. The stock has a fifty day simple moving average of $60.38 and a 200 day simple moving average of $71.04. The company has a quick ratio of 1.16, a current ratio of 1.81 and a debt-to-equity ratio of 1.10.

H.B. Fuller (NYSE:FUL) last posted its quarterly earnings data on Wednesday, January 15th. The specialty chemicals company reported $0.92 earnings per share for the quarter, missing analysts’ consensus estimates of $1.00 by ($0.08). The company had revenue of $923.00 million during the quarter, compared to analyst estimates of $916.84 million. H.B. Fuller had a net margin of 3.65% and a return on equity of 12.01%. The business’s revenue for the quarter was up 2.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $1.32 earnings per share. Sell-side analysts expect that H.B. Fuller will post 4.07 EPS for the current year.

H.B. Fuller Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 20th. Stockholders of record on Thursday, February 6th were given a dividend of $0.2225 per share. The ex-dividend date was Thursday, February 6th. This represents a $0.89 dividend on an annualized basis and a dividend yield of 1.65%. H.B. Fuller’s dividend payout ratio (DPR) is presently 38.53%.

Hedge Funds Weigh In On H.B. Fuller

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Geode Capital Management LLC boosted its position in shares of H.B. Fuller by 1.5% during the 3rd quarter. Geode Capital Management LLC now owns 1,258,752 shares of the specialty chemicals company’s stock worth $99,939,000 after purchasing an additional 18,734 shares in the last quarter. Lord Abbett & CO. LLC boosted its position in shares of H.B. Fuller by 79.8% during the 3rd quarter. Lord Abbett & CO. LLC now owns 730,058 shares of the specialty chemicals company’s stock worth $57,952,000 after purchasing an additional 324,056 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of H.B. Fuller by 17.2% during the 4th quarter. Bank of New York Mellon Corp now owns 554,947 shares of the specialty chemicals company’s stock worth $37,448,000 after purchasing an additional 81,558 shares in the last quarter. S&CO Inc. boosted its position in shares of H.B. Fuller by 0.3% during the 3rd quarter. S&CO Inc. now owns 267,192 shares of the specialty chemicals company’s stock worth $21,209,000 after purchasing an additional 920 shares in the last quarter. Finally, Kennedy Capital Management LLC boosted its position in shares of H.B. Fuller by 13.4% during the 4th quarter. Kennedy Capital Management LLC now owns 127,896 shares of the specialty chemicals company’s stock worth $8,630,000 after purchasing an additional 15,100 shares in the last quarter. Institutional investors own 95.93% of the company’s stock.

H.B. Fuller Company Profile

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.